Standout Papers

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction... 2019 2026 2021 2023 434
  1. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes (2020)
    Sandeep R. Das, Brendan M. Everett et al. Journal of the American College of Cardiology
  2. Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure (2019)
    Brendan M. Everett, Jan H. Cornel et al. Circulation

Immediate Impact

5 from Science/Nature 74 standout
Sub-graph 1 of 18

Citing Papers

Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
2023 Standout
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
2023 Standout
11 intermediate papers

Works of Brendan M. Everett being referenced

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
2020 Standout
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
2018
and 6 more

Author Peers

Author Last Decade Papers Cites
Brendan M. Everett 1559 2169 1602 90 5.0k
Anand Rohatgi 1376 2331 1697 98 5.6k
Erik H. Serné 1213 2105 963 152 5.5k
Danielle M. Brennan 865 2333 2723 90 5.2k
Jane Armitage 1158 1149 2563 90 5.6k
Jackie A. Cooper 1216 1451 1584 122 5.5k
Eric de Groot 1390 2192 2409 97 5.7k
Michael Mauer 2332 1377 1399 193 9.9k
Shih‐Jen Hwang 1061 3010 849 102 6.2k
Brian A. Ference 1947 1514 3426 66 6.0k
Enrique Z. Fisman 1721 2055 1027 164 4.8k

All Works

Loading papers...

Rankless by CCL
2026